ROBERT HELMLY, M.D.
Cardiovascular Disease Physician in EASTON, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROBERT HELMLY, M.D. reported a CMS MIPS final score of 86.672/100 — above the 83.1 national average — and filed 1,109 Medicare Part D claims in 2023.
- 86.672/100
- MIPS score · +4 vs avg
- 1K
- Part D claims, 2023
- 72%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROBERT HELMLY, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
87 Top 48% higher than 52% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
ROBERT HELMLY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ROBERT HELMLY, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Cardiovascular Disease Physician compares to other specialties among Maryland providers
Cardiovascular Disease Physician share within Maryland
Cardiovascular Disease Physician is one of the more visible NUCC categories in Maryland
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ROBERT HELMLY, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 86.672/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) — 86.672/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Cardiovascular Disease Physician US NPIs
86.672/100 MIPS final score — 3.6 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 90.0395. Cost dim: 65.5337.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROBERT HELMLY, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 500 CADMUS LN STE 207, EASTON, MD, 21601, with a listed phone of (410) 822-5571. NPI 1174535454 was issued on 08/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HELMLY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,109 prescription claims written by this provider, covering 268 Medicare beneficiaries and totaling roughly $378K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.672/100 for the 2023 performance year (Quality 90.0395, Cost 65.5337), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174535454 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROBERT HELMLY, M.D.'s current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT HELMLY, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$348
Largest payer
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
28% brand-name claims vs 72% generic, on 1,109 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,927
- Total Day Supply
- 87,556
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $357K
- Generic Drug Cost
- $20K
Patient Demographics
- Average Patient Age
- 77.1 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 15, 65-74: 77, 75-84: 128, 85+: 48
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROBERT HELMLY, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
142 claims
- Metoprolol Succinate
Metoprolol Succinate
121 claims
- Atorvastatin Calcium
Atorvastatin Calcium
96 claims
- Losartan Potassium
Losartan Potassium
59 claims
- Furosemide
Furosemide
57 claims
- Entresto 53
Entresto
53 claims
- Amlodipine Besylate 50
Amlodipine Besylate
50 claims
- Carvedilol 49
Carvedilol
49 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 142 |
| Metoprolol Succinate | 121 |
| Atorvastatin Calcium | 96 |
| Losartan Potassium | 59 |
| Furosemide | 57 |
| Entresto Sacubitril/Valsartan | 53 |
| Amlodipine Besylate | 50 |
| Carvedilol | 49 |
| Metoprolol Tartrate | 42 |
| Lisinopril | 37 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How ROBERT HELMLY, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
ROBERT HELMLY, M.D.'s 1,109 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as HELMLY.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is ROBERT HELMLY, M.D.'s specialty? ▼
How much does ROBERT HELMLY, M.D. prescribe under Medicare Part D? ▼
What is ROBERT HELMLY, M.D.'s Medicare quality score? ▼
Where is ROBERT HELMLY, M.D. located? ▼
What is ROBERT HELMLY, M.D.'s NPI number? ▼
Does ROBERT HELMLY, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does ROBERT HELMLY, M.D. prescribe most often? ▼
Does ROBERT HELMLY, M.D. accept Medicare? ▼
How can I verify ROBERT HELMLY, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology